Ann: Supplementary NYR-BI03 Study Confirm Strong Cardioprotection, page-44

  1. 1,213 Posts.
    lightbulb Created with Sketch. 155
    lie and deceive lol coming from a troll that couldn’t even answer a fellow posters question about what the difference is between AGN and NYR lol then tries to troll the poster that is actually providing facts.

    Thanks mate I’ll enjoy the sunshine and when my gut tells me a raise is coming to get that 7-8 million cash to run this to phase 2 and to non dilutive funding from Walter Reed and cardiovascular indication I’m confident that the company doesn’t want to disrupt the share price on its trajectory north

    So if they have 5 million in cash they need 2-3 million dollars based on their quarterly burn rate, patent and 1.5 million they need for phase 1 and this will begin to rerate into phase 1 and beyond as investors are comfortable they have the funds. Let’s see who’s right Zecs
    Last edited by Bendunstan: 23/10/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
24.5¢
Change
0.000(0.00%)
Mkt cap ! $51.67M
Open High Low Value Volume
24.5¢ 25.0¢ 23.5¢ $211.2K 865.1K

Buyers (Bids)

No. Vol. Price($)
2 17007 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 85141 1
View Market Depth
Last trade - 15.50pm 23/06/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.